Position in ANIK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$36,516
+$28,163 QoQ
Shares Held
2,496
+611.1% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 134 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MEEDER ASSET MANAGEMENT INC holds $5,449,522 across 11 Drug Manufacturers - Specialty & Generic names. ANIK ranks #5 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
9,236 | $5,004,338 | |
| 2 | ZTS |
Zoetis Inc.
|
2,789 | $200,416 | |
| 3 | LQDA |
Liquidia Corp
|
1,021 | $81,404 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
1,969 | $61,826 | |
| 5 | ANIK |
Anika Therapeutics, Inc.
This page
|
2,496 | $36,516 | |
| 6 | PRGO |
PERRIGO Co plc
|
1,976 | $20,530 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
2,057 | $17,237 | |
| 8 | VTRS |
Viatris Inc
|
1,023 | $16,244 |
All Filings in ANIK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,516 | 2,496 | Shares | Sole | 2026-08-07 | |
| 2022-09-30 | $8,353 | 351 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,294 | 58 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $979 | 39 | Shares | Defined | 2022-05-10 | |
| 2021-09-30 | $766 | 18 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $779 | 18 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $1,835 | 45 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $814 | 18 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $778 | 22 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $415 | 11 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||